willdate
Carag Bioresorbable Septal Occluder approved for US IDE trial
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been granted for the Carag Bioresorbable Septal Occluder (CBSO).
The CE-marked CBSO is...
PCR e-Course 2020: Roll-in trial finds high device success rate for...
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high implant success rate and a low procedural complication rate in...
PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs...
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, major bleeding and all-cause mortality, in atrial fibrillation (AF) patients with a high...
Smartphone app uses can identify lung congestion in heart failure patients
Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing early intervention before their condition deteriorates, a study presented...
Philips gains FDA clearance for the use of its ultrasound portfolio...
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a wide range of...
FDA approves update to cardiac imaging system to aid COVID-19 diagnostics
The US Food and Drug Administration (FDA) has expedited clearance of an update to software from Caption Health, a medical artificial intelligence (AI) company,...
Boston Scientific announces positive PINNACLE FLX study results
Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left...
LifeSignals receives CE mark for the ECG Remote Monitoring Patch
LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a disposable wireless remote monitoring system, intended for use by healthcare...
iRhythm offers home enrolment of Zio monitoring devices
iRhythm Technologies has announced a virtual platform to support patients and clinicians in the wake of COVID-19 by offering home enrolment for the company’s...
US heart societies express concern over using hydroxychloroquine and azithromycin for...
Presidents of leading cardiac organisations, including the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS), have...
Webinar: Cardiovascular specialists detail COVID-19 strategies
Cardiovascular specialists from across the globe shared current knowledge and key experience of managing COVID-19 patients as part of a webinar organised by the...
AHA issues oxygenation and ventilation guidance for healthcare providers
The American Heart Association (AHA), in conjunction with the American Association for Respiratory Care (AARC) and American Society of Anesthesiologists (ASA) is offering guidance...
Athena Poppas begins ACC presidency
Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC). Her term officially began at the close of the...
Cardiologists share COVID-19 insights
Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, in a series of videos produced by the European Society of...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...
Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolute Onyx drug-eluting stent (DES) in high bleeding risk (HBR)...
Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis...
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low risk of death or disabling stroke at 30 days in...
AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research
The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...
Append Medical share clinical proof-of-concept results for internal sealing of LAA
Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and...
VitalConnect adds arrhythmia detection to its remote monitoring software
VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, VitalConnect now offers physicians the ability to...
AI-guided cardiac imaging system given FDA authorisation
The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acquisition of cardiac ultrasound, or echocardiography, images. The...
First patient enrolled in PREDICT-LAA clinical trial
FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial.
The trial is led by Righshospitalet (Copenhagen, Denmark) and aims...
ACC makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes within its senior staff. The College said that the staff changes...
FDA grants Breakthrough designation for ECG-based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital health and artificial intelligence (AI) company Eko for an echocardiogram...
European trial data ‘reinforce’ safety profile and efficacy of Lixiana
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...
AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary...
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor System at the 2019 American Heart Association (AHA) Scientific Sessions (16–18 November,...
Left atrial appendage closure associated with a decreased stroke risk in...
Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...
